Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ichiro M Omori

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
The Cochrane Database of Systematic Reviews|April 17, 2009
Sulpiride versus placebo for schizophreniaIchiro M Omori, Jijun Wang
Schizophrenia Bulletin|January 12, 2010
Sulpiride augmentation for schizophreniaJijun Wang, Ichiro M Omori, Mark Fenton, et al.
The Cochrane Database of Systematic Reviews|January 22, 2010
Sulpiride augmentation for schizophreniaJijun Wang, Ichiro M Omori, Mark Fenton, et al.
BMC Psychiatry|December 21, 2007
Can pill placebo augment cognitive-behavior therapy for panic disorder?Toshi A Furukawa, Norio Watanabe, Ichiro M Omori, et al.
JAMA|February 8, 2007
Association between unreported outcomes and effect size estimates in Cochrane meta-analysesToshi A Furukawa, Norio Watanabe, Ichiro M Omori, et al.
Scientific Reports|June 9, 2021
Elucidation of the relationship between sensory processing and white matter using diffusion tensor imaging tractography in young adultsDaichi Shiotsu, Minyoung Jung, Kaie Habata, et al.
The Cochrane Database of Systematic Reviews|December 14, 2011
Mirtazapine versus other antidepressive agents for depressionNorio Watanabe, Ichiro M Omori, Atsuo Nakagawa, et al.
Journal of Psychiatric Research|July 11, 2006
The differential impact of executive attention dysfunction on episodic memory in obsessive-compulsive disorder patients with checking symptoms vs. those with washing symptomsIchiro M Omori, Yoshie Murata, Tomoaki Yamanishi, et al.
Translational Psychiatry|December 7, 2021
Relationship between sensory characteristics and cortical thickness/volume in autism spectrum disordersKaie Habata, Yongjeon Cheong, Taku Kamiya, et al.
The Cochrane Database of Systematic Reviews|March 19, 2010
Fluvoxamine versus other anti-depressive agents for depressionIchiro M Omori, Norio Watanabe, Atsuo Nakagawa, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
The Cochrane Database of Systematic Reviews|April 17, 2009
Sulpiride versus placebo for schizophreniaIchiro M Omori, Jijun Wang
Schizophrenia Bulletin|January 12, 2010
Sulpiride augmentation for schizophreniaJijun Wang, Ichiro M Omori, Mark Fenton, et al.
The Cochrane Database of Systematic Reviews|January 22, 2010
Sulpiride augmentation for schizophreniaJijun Wang, Ichiro M Omori, Mark Fenton, et al.
BMC Psychiatry|December 21, 2007
Can pill placebo augment cognitive-behavior therapy for panic disorder?Toshi A Furukawa, Norio Watanabe, Ichiro M Omori, et al.
JAMA|February 8, 2007
Association between unreported outcomes and effect size estimates in Cochrane meta-analysesToshi A Furukawa, Norio Watanabe, Ichiro M Omori, et al.
Scientific Reports|June 9, 2021
Elucidation of the relationship between sensory processing and white matter using diffusion tensor imaging tractography in young adultsDaichi Shiotsu, Minyoung Jung, Kaie Habata, et al.
The Cochrane Database of Systematic Reviews|December 14, 2011
Mirtazapine versus other antidepressive agents for depressionNorio Watanabe, Ichiro M Omori, Atsuo Nakagawa, et al.
Journal of Psychiatric Research|July 11, 2006
The differential impact of executive attention dysfunction on episodic memory in obsessive-compulsive disorder patients with checking symptoms vs. those with washing symptomsIchiro M Omori, Yoshie Murata, Tomoaki Yamanishi, et al.
Translational Psychiatry|December 7, 2021
Relationship between sensory characteristics and cortical thickness/volume in autism spectrum disordersKaie Habata, Yongjeon Cheong, Taku Kamiya, et al.
The Cochrane Database of Systematic Reviews|March 19, 2010
Fluvoxamine versus other anti-depressive agents for depressionIchiro M Omori, Norio Watanabe, Atsuo Nakagawa, et al.
Pageof 3